Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Fey

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2004
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of CalreticulinDaniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari, Karen Price, Richard D Gelber, et al.
Breast Cancer Research and Treatment|January 13, 2009
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a centuryOlivia Pagani, Karen N Price, Richard D Gelber, et al.
The Journal of Experimental Medicine|May 19, 2004
Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophilsFrank Altznauer, Sibylla Martinelli, Shida Yousefi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK)Michele Ghielmini, Shu-Fang Hsu Schmitz, Sergio Cogliatti, et al.
Annals of Hematology|March 7, 2007
CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older ageMarry M van den Heuvel-Eibrink, Bronno van der Holt, Alan K Burnett, et al.
Journal of Leukocyte Biology|March 10, 2007
The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cellsMattia Rizzi, Mario P Tschan, Christian Britschgi, et al.
Journal of Leukocyte Biology|September 17, 2013
The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APLMagali Humbert, Elena A Federzoni, Adrian Britschgi, et al.
Breast Cancer Research and Treatment|October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93Olivia Pagani, Shari Gelber, Edda Simoncini, et al.
Blood|September 29, 2011
Autologous peripheral blood stem cell transplantation for acute myeloid leukemiaEdo Vellenga, Wim van Putten, Gert J Ossenkoppele, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2004
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of CalreticulinDaniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari, Karen Price, Richard D Gelber, et al.
Breast Cancer Research and Treatment|January 13, 2009
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a centuryOlivia Pagani, Karen N Price, Richard D Gelber, et al.
The Journal of Experimental Medicine|May 19, 2004
Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophilsFrank Altznauer, Sibylla Martinelli, Shida Yousefi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK)Michele Ghielmini, Shu-Fang Hsu Schmitz, Sergio Cogliatti, et al.
Annals of Hematology|March 7, 2007
CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older ageMarry M van den Heuvel-Eibrink, Bronno van der Holt, Alan K Burnett, et al.
Journal of Leukocyte Biology|March 10, 2007
The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cellsMattia Rizzi, Mario P Tschan, Christian Britschgi, et al.
Journal of Leukocyte Biology|September 17, 2013
The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APLMagali Humbert, Elena A Federzoni, Adrian Britschgi, et al.
Breast Cancer Research and Treatment|October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93Olivia Pagani, Shari Gelber, Edda Simoncini, et al.
Blood|September 29, 2011
Autologous peripheral blood stem cell transplantation for acute myeloid leukemiaEdo Vellenga, Wim van Putten, Gert J Ossenkoppele, et al.
Pageof 7